Please login to the form below
Ethan Knowlden leaves Novartis for Complete Genomics
Joins genome sequencing firm as senior VP, general counsel
Complete Genomics has appointed Ethan Knowlden as the company's new senior VP, general counsel.
Knowlden joins from Novartis Vaccines and Diagnostics, where he was VP of business development and licensing, and corporate counsel. He spent more than 13 years at Novartis and its predecessor Chiron Corp.
In his new role, he will provide legal advice to Complete Genomics, which is a US subsidiary of the China-based genomics firm BGI-Shenzhen.
Complete Genomics is one of the leading companies working in human genomic sequencing, having sequenced more than 15,000 whole human genomes.
"Whole human genome sequencing will dramatically change the way in which healthcare is practiced in many countries during the next decade and I am delighted to be part of the Complete team at this transformative time," said Knowlden.
COVID-19 Updates and Daily News
Featured jobs
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Merck’s Keytruda hits the mark in triple negative breast cancer
- Moderna to begin pivotal phase 3 trial of COVID-19 vaccine in July
- Impetus Digital Fireside Chat with Susanne Somerville of Chronicled
- Impetus Digital Fireside Chat with Bechara Saab of Mobio Interactive
- FDA delays review of Novartis’ MS drug ofatumumab
- Sanofi makes ‘best-in-class’ claim for Sarclisa in myeloma
- Q&A: Kay Wesley
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
